Pacira Pharmaceuticals reported $15.22M in Trade Creditors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acelrx Pharmaceuticals ACRX:US USD 2M 397K
Amerisourcebergen ABC:US USD 41.76B 1.57B
Astellas Pharma 4503:JP JPY 134.24B 12.3B
Cara Therapeutics CARA:US USD 9.6M 5.61M
Coherus Biosciences CHRS:US USD 11.53M 1.61M
Depomed DEPO:US USD 5.99M 2.38M
Endo International Ordinary Shares ENDP:US USD 85M 5.64M
Heron Therapeutics HRTX:US USD 6.55M 7.26M
Horizon Pharma HZNP:US USD 155.8M 123.69M
Ironwood Pharmaceuticals IRWD:US USD 483K 312K
Lannett LCI:US USD 33.16M 9.1M
Nektar Therapeutics NKTR:US USD 12.98M 7.65M
Omeros OMER:US USD 5.99M 11.1M
Pacira Pharmaceuticals PCRX:US USD 15.22M 2.29M
Perrigo Ordinary Shares PRGO:US USD 537.3M 75.9M
Revance Therapeutics RVNC:US USD 4.55M 3.8M
Supernus Pharmaceuticals SUPN:US USD 10.54M 5.47M
Teva Pharmaceutical TEVA:IT USD 1.89B 252M
Xeris Pharmaceuticals Inc XERS:US USD 4.61M 690K
Zoetis ZTS:US USD 405M 32M